TK-129

N/A

Report date: 2022/09/19 15:02:25
NME

Base Information

Drug NameTK-129
Drug Alias NameTK-129
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysine-specific demethylase 5B inhibitors
TargetsLysine-specific demethylase 5B
Therapy Area/IndicationsEndomyocardial Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhengzhou University
China Registration ClassN/A

Develop Information

Active CompaniesZhengzhou University
Inactive CompaniesN/A
Active IndicationsEndomyocardial Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A